Solara Active Pharma Sciences Limited (BOM:541540)
India · Delayed Price · Currency is INR 683.50
+1.60 (0.23%)
At close: Oct 7, 2026
BOM:541540 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 33,014 | 20,499 | 24,661 | 13,353 | 11,787 | 23,977 | |
Market Cap Growth | 11.28% | -16.88% | 84.69% | 13.28% | -50.84% | -52.10% |
Enterprise Value | 39,373 | 26,948 | 33,026 | 23,165 | 21,509 | 31,550 |
Last Close Price | 681.90 | 425.05 | 512.70 | 343.26 | 302.67 | 613.03 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 4566.82 | - | - | - |
PS Ratio | 2.30 | 1.50 | 1.92 | 1.04 | 0.82 | 1.89 |
PB Ratio | 2.62 | 1.63 | 2.25 | 1.43 | 0.79 | 1.57 |
P/TBV Ratio | 3.80 | 2.37 | 3.53 | 2.54 | 1.09 | 2.20 |
P/FCF Ratio | 32.91 | 20.48 | 14.27 | 19.69 | 26.23 | - |
P/OCF Ratio | 21.54 | 13.41 | 11.59 | 12.27 | 7.54 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.75 | 1.97 | 2.57 | 1.80 | 1.49 | 2.49 |
EV/EBITDA Ratio | 20.70 | 14.78 | 16.29 | - | 16.36 | 39.77 |
EV/EBIT Ratio | 44.21 | 30.57 | 30.57 | - | 77.96 | - |
EV/FCF Ratio | 39.26 | 26.92 | 19.10 | 34.16 | 47.86 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.55 | 0.55 | 0.73 | 1.08 | 0.67 | 0.68 |
Debt / EBITDA Ratio | 3.62 | 3.69 | 3.87 | - | 7.55 | 12.63 |
Debt / FCF Ratio | - | 6.86 | 4.61 | 14.92 | 22.54 | - |
Net Debt / Equity Ratio | 0.50 | 0.54 | 0.72 | 1.07 | 0.67 | 0.65 |
Net Debt / EBITDA Ratio | 3.34 | 3.72 | 3.91 | -10.24 | 7.64 | 12.49 |
Net Debt / FCF Ratio | - | 6.79 | 4.58 | 14.79 | 22.34 | -2.20 |
Asset Turnover | - | 0.60 | 0.56 | 0.49 | 0.49 | 0.46 |
Inventory Turnover | - | 2.31 | 1.95 | 1.88 | 1.48 | 1.63 |
Quick Ratio | - | 0.53 | 0.41 | 0.33 | 0.53 | 0.56 |
Current Ratio | - | 0.96 | 0.77 | 0.64 | 1.08 | 1.17 |
Return on Equity (ROE) | - | -0.63% | 0.05% | -46.49% | -1.47% | -3.74% |
Return on Assets (ROA) | - | 2.41% | 2.95% | -4.70% | 0.59% | -0.58% |
Return on Invested Capital (ROIC) | 4.65% | 4.61% | 5.64% | -8.89% | 1.10% | -1.15% |
Return on Capital Employed (ROCE) | - | 6.10% | 8.40% | -17.80% | 1.50% | -1.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -0.05% | -0.36% | 0.02% | -42.49% | -1.88% | -2.43% |
FCF Yield | 3.04% | 4.88% | 7.01% | 5.08% | 3.81% | -18.80% |
Buyback Yield / Dilution | -13.50% | -10.44% | -4.44% | -6.13% | -0.15% | -4.75% |
Total Shareholder Return | -13.50% | -10.44% | -4.44% | -6.13% | -0.15% | -4.75% |